EntryPoint Capital’s Autolus Therapeutics AUTL Stock Holding History

EntryPoint Capital’s Portfolio AUTL Stock Details AUTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell
2024 Q4	$450K	Buy
2024 Q2	–	Sell
2024 Q1	$137K	Buy
2023 Q4	$64.9K	Buy